rp 73401 has been researched along with Emesis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Djuric, S; Hanney, B; He, W; Huang, FC; Liang, G; Mason, J; Miller, B; Souness, J | 1 |
| Bachert, EL; Cheng, JB; Cohan, VL; Duplantier, AJ; Jenkinson, TH; Kraus, KG; McKechney, MW; Pillar, JD; Watson, JW | 1 |
| He, J; Ke, H; Peng, T; Qi, B; Shi, J | 1 |
| Akuta, K; Hirose, R; Ichimura, M; Manabe, H; Nonaka, H; Ohshima, E; Sato, S; Yanagawa, K | 1 |
| Buckley, G; Cooper, N; Dyke, HJ; Galleway, F; Gowers, L; Gregory, JC; Hannah, DR; Haughan, AF; Hellewell, PG; Kendall, HJ; Lowe, C; Maxey, R; Montana, JG; Naylor, R; Picken, CL; Runcie, KA; Sabin, V; Tuladhar, BR; Warneck, JB | 1 |
1 review(s) available for rp 73401 and Emesis
| Article | Year |
|---|---|
Advances in the Development of Phosphodiesterase-4 Inhibitors.
Topics: Animals; Cyclic Nucleotide Phosphodiesterases, Type 4; Drug Development; Drug Discovery; Humans; Molecular Structure; Phosphodiesterase 4 Inhibitors; Protein Conformation; Quinolones; Vomiting | 2020 |
4 other study(ies) available for rp 73401 and Emesis
| Article | Year |
|---|---|
Novel cyclic compounds as potent phosphodiesterase 4 inhibitors.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzamides; Brain; Cyclic Nucleotide Phosphodiesterases, Type 4; Dogs; Endotoxemia; Female; Guinea Pigs; In Vitro Techniques; Lipopolysaccharides; Macrophages, Peritoneal; Male; Mice; Mice, Inbred BALB C; Models, Molecular; Phosphodiesterase Inhibitors; Pyridines; Structure-Activity Relationship; Tumor Necrosis Factor-alpha; Vomiting | 1998 |
SAR of a series of 5,6-dihydro-(9H)-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-alpha]pyridines as potent inhibitors of human eosinophil phosphodiesterase.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Biological Availability; Cyclic Nucleotide Phosphodiesterases, Type 4; Dogs; Eosinophils; Female; Ferrets; Heterocyclic Compounds, 3-Ring; Humans; In Vitro Techniques; Isoenzymes; Male; Phosphodiesterase Inhibitors; Pyrazoles; Pyridines; Rats; Recombinant Proteins; Structure-Activity Relationship; Triazoles; Vomiting | 2007 |
Correlation between emetic effect of phosphodiesterase 4 inhibitors and their occupation of the high-affinity rolipram binding site in Suncus murinus brain.
Topics: Animals; Benzamides; Binding Sites; Binding, Competitive; Brain; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Kinetics; Male; Molecular Structure; Naphthyridines; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Pyridines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Rolipram; Shrews; Tritium; Vomiting; Xanthines | 2007 |
7-Methoxybenzofuran-4-carboxamides as PDE 4 inhibitors: a potential treatment for asthma.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Administration, Oral; Animals; Asthma; Benzamides; Benzofurans; Cyclic Nucleotide Phosphodiesterases, Type 4; Eosinophilia; Guinea Pigs; Inhibitory Concentration 50; Phosphodiesterase Inhibitors; Pyridines; Rolipram; Structure-Activity Relationship; Vomiting | 2000 |